Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive ...

Symbicort was first FDA-approved in 2006 as a treatment for asthma, followed by an extension to its label covering COPD in 2009 ... containing budesonide, an inhaled corticosteroid that treats ...

Inhaled corticosteroids ... GlaxoSmithKline) and Symbicort (budesonide + formoterol fumarate dihydrate; AstraZeneca), which are ICS–LABA combinations, are other popular COPD drugs.

"Today's results are significant as they show for the first time the positive effect of directly switching to Ultibro Breezhaler from other COPD treatments, such as inhaled steroid-containing ...

Compared with control patients, invited patients spent less out-of-pocket. Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for ...